Jalissa Katrini

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Extended Endocrine Therapy and Survival for Breast Cancer Subtypes in Premenopausal Patients.

Extended Endocrine Therapy and Survival for Breast Cancer Subtypes in Premenopausal Patients.

Journal: JAMA network open
Published: May 04, 2026

Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study.

Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 15, 2026

Rational adjustment of dose to reduce adverse reactions (RADAR) in patients with platinum-sensitive recurrent ovarian cancer: Results from the phase II NEWTON trial (ENGOT-ov49).

Rational adjustment of dose to reduce adverse reactions (RADAR) in patients with platinum-sensitive recurrent ovarian cancer: Results from the phase II NEWTON trial (ENGOT-ov49).

Journal: European journal of cancer (Oxford, England : 1990)
Published: January 08, 2026

Molecular tumour board in gastrointestinal cancers.

Molecular tumour board in gastrointestinal cancers.

Journal: ESMO open
Published: January 21, 2025

Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort study.

Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort study.

Journal: Gynecologic oncology
Published: December 05, 2024

Metastasis-directed stereotactic radiotherapy and systemic treatment continuation for patients with oligoprogressive metastatic breast cancer.

Metastasis-directed stereotactic radiotherapy and systemic treatment continuation for patients with oligoprogressive metastatic breast cancer.

Journal: European journal of cancer (Oxford, England : 1990)
Published: November 11, 2024

The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit.

The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit.

Journal: Cancers
Published: October 10, 2024

Molecular tumor board in patients with metastatic breast cancer.

Molecular tumor board in patients with metastatic breast cancer.

Journal: Breast cancer research and treatment
Published: August 27, 2024

Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study.

Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study.

Journal: The oncologist
Published: August 19, 2024

Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs".

Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs".

Journal: Cancers
Published: July 16, 2024

Interstitial lung disease in patients enrolled in early-phase clinical trials: the ILDE study.

Interstitial lung disease in patients enrolled in early-phase clinical trials: the ILDE study.

Journal: ESMO open
Published: April 09, 2024

Unveiling the Untapped Potential of Antibody Drug Conjugates in Precision Oncology.

Unveiling the Untapped Potential of Antibody Drug Conjugates in Precision Oncology.

Journal: JAMA oncology
Published: March 14, 2024
Showing 1-12 of 15

Last Updated: 09/26/2026